Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Restenosis and Hyperplasia: Animal Models.

Bayes-Genis1, Kantor, Keelan

  • 1Division of Cardiovascular Diseases, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA. schwartzr@mayo.edu

Current Interventional Cardiology Reports
|November 30, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Children systemic lupus erythematosus-associated pancreatitis.

Arthritis research & therapy·2024
Same author

Boracic Acid in the Treatment of Leucorrhœa.

Buffalo medical and surgical journal·2023
Same author

The difficult forceps case.

Irish journal of medical science·2010
Same author

Lupus erythematosus.

Archives of pediatrics·2010
Same author

Tyrosine Phosphorylation of Moesin in Arachidonic Acid-Stimulated Human Platelets.

Journal of thrombosis and thrombolysis·2001
Same author

Interobserver Reproducibility and Biological Variability of the Surgicutt II Bleeding Time.

Journal of thrombosis and thrombolysis·2001
Same journal

Rashkind and Clamshell Device Closure of Ventricular Septal Defect.

Current interventional cardiology reports·2001
Same journal

The Role of the 'Sideris' Devices in the Occlusion of Ventricular Septal Defects.

Current interventional cardiology reports·2001
Same journal

A Comparison of Tirofiban and Abciximab in Patients Undergoing Coronary Stent Implantation: Rationale, Design, and Results of the TARGET Trial.

Current interventional cardiology reports·2001
Same journal

Diabetes and Coronary Intervention: Special Considerations for Antithrombotic Therapy.

Current interventional cardiology reports·2001
Same journal

'Facilitated' PCI for Acute MI: PCI with Lysis and Platelet Inhibition.

Current interventional cardiology reports·2001
Same journal

Restenosis and Reocclusion after Recanalization of an Occluded Coronary Artery: Is There a Light at the End of This Tunnel?

Current interventional cardiology reports·2001
See all related articles

Animal models are crucial for studying coronary restenosis, the re-narrowing of arteries after procedures. However, current models like the rat carotid model have limitations in predicting clinical outcomes, highlighting a gap in understanding vascular healing.

Area of Science:

  • Cardiovascular Research
  • Translational Medicine

Background:

  • Coronary restenosis following percutaneous coronary interventions (PCI) remains a significant clinical challenge, despite advancements in stenting technologies.
  • Effective prevention and treatment strategies depend on robust experimental animal models to elucidate pathophysiologic mechanisms.

Purpose of the Study:

  • To review and compare commonly utilized animal models for studying coronary artery restenosis.
  • To highlight the discrepancies and limitations among these models, particularly concerning their predictive value for clinical outcomes.

Main Methods:

  • Review of established animal models for coronary artery restenosis.
  • Comparative analysis of the strengths and weaknesses of each model.
  • Discussion of the variable responses to vascular injury observed across different models.

Related Experiment Videos

Main Results:

  • The rat carotid artery model, while historically significant, has demonstrated poor predictability for clinical restenosis outcomes.
  • Discrepancies in vascular healing responses among models necessitate careful consideration during therapy assessment.
  • A fundamental lack of understanding of molecular mechanisms governing vascular repair after injury is evident.

Conclusions:

  • The selection and interpretation of findings from animal models of coronary restenosis must account for inter-model variability.
  • Improved animal models are needed to accurately predict the efficacy of novel therapies for preventing restenosis.
  • Further research into the molecular basis of vascular healing is essential for advancing clinical restenosis management.